Synthesis of β‐Substituted γ‐Aminobutyric Acid Derivatives through Enantioselective Photoredox Catalysis

β‐Substituted chiral γ‐aminobutyric acids feature important biological activities and are valuable intermediates for the synthesis of pharmaceuticals. Herein, an efficient catalytic enantioselective approach for the synthesis of β‐substituted γ‐aminobutyric acid derivatives through visible‐light‐induced photocatalyst‐free asymmetric radical conjugate additions is reported. Various β‐substituted γ‐aminobutyric acid analogues, including previously inaccessible derivatives containing fluorinated quaternary stereocenters, were obtained in good yields (42–89 %) and with excellent enantioselectivity (90–97 % ee). Synthetically valuable applications were demonstrated by providing straightforward synthetic access to the pharmaceuticals or related bioactive compounds (S)‐pregabalin, (R)‐baclofen, (R)‐rolipram, and (S)‐nebracetam.     

Stereoselective Total Synthesis of the Natural Oxylipin (6R,7E,9R,10S)‐6,9,10‐Trihydroxyoctadec‐7‐enoic Acid

The stereoselective total synthesis of the natural oxylipin, (6R,7E,9R,10S)‐6,9,10‐trihydroxyoctadec‐7‐enoic acid, has been accomplished using nonanal and hexane‐1,6‐diol as the starting materials. The synthesis involves Sharpless kinetic resolution, asymmetric epoxidation, and olefin cross‐metathesis as the key steps.     

Asymmetric Synthesis of Complicated Bicyclic and Tricyclic Polypropanoates via the Double Diels‐Alder Addition of 2,2′‐Ethylidenebis[3,5‐dimethylfuran]

A new, non‐iterative method for the asymmetric synthesis of long‐chain and polycyclic polypropanoate fragments starting from 2,2′‐ethylidenebis[3,5‐dimethylfuran] ( 2 ) has been developed. Diethyl (2E,5E)‐4‐oxohepta‐2,5‐dienoate ( 6 ) added to 2 to give a single meso‐adduct 7 containing nine stereogenic centers. Its desymmetrization was realized by hydroboration with (+)‐IpcBH₂ (isopinocampheylborane), leading to diethyl (1S,2R,3S,4S,4aS,7R,8R,8aR,9aS,10R,10aR)‐1,3,4,7,8,8a,9,9a‐octahydro‐3‐hydroxy‐2,4,5,7,10‐pentamethyl‐9‐oxo‐2H,10H‐2,4a : 7,10a‐diepoxyanthracene‐1,8‐dicarboxylate ((+)‐ 8 ; 78% e.e.). Alternatively, 7 was converted to meso‐(1R,2R,4R,4aR,5S,7S,8S,8aR,9aS,10s,10aS)‐1,8‐bis(acetoxymethyl)‐1,8,8a,9a‐tetrahydro‐2,4,5,7,10‐pentamethyl‐2H‐10H‐2,4a : 7,10a‐diepoxyanthracene‐3,6,9(4H,5H,7H)‐trione ( 32 ) that was reduced enantioselectively by BH₃ catalyzed by methyloxazaborolidine 19 derived from L ‐diphenylprolinol giving (1S,2S,4S,4aS,5S,6R,7R,8R,8aS,9aR,10R,10aS)‐1,8‐bis(acetoxymethyl)‐1,8,8a,9a‐tetrahydro‐6‐hydroxy‐2,4,5,7,10‐pentamethyl‐2H,10H‐2,4a : 7,10a‐diepoxyanthracene‐3,9(4H,7H)‐dione ((−)‐ 33 ; 90% e.e.). Chemistry was explored to carry out chemoselective 7‐oxabicyclo[2.2.1]heptanone oxa‐ring openings and intra‐ring C−C bond cleavage. Polycyclic polypropanoates such as (1R,2S,3R,4R,4aR,5S,6R,7S,8R,9R,10R,11S,12aR)‐1‐(ethoxycarbonyl)‐1,3,4,7,8,9,10,11,12,12a‐decahydro‐3,11‐dihydroxy‐2,4,5,7,9‐pentamethyl‐12‐oxo‐2H,5H‐2,4a : 6,9 : 6,11‐triepoxybenzocyclodecene‐10,8‐carbolactone ( 51 ), (1S,2R,3R,4R,4aS,5S,7S,8R,9R,10R,12S,12aS)‐1,10‐bis(acetoxymethyl)tetradecahydro‐8‐(methoxymethoxy)‐2,4,5,7,9‐pentamethyl‐3,9‐bis{[2‐(trimethylsilyl)ethoxy]methoxy}‐6,11‐epoxycyclodecene‐4a,6,11,12‐tetrol ((+)‐ 83 ), and (1R,2R,3R,4aR,4bR,5S,6R, 7R,8R,8aS,9S,10aR)‐3,5‐bis(acetoxymethyl)‐4a,8a‐dihydroxy‐1‐(methoxymethoxy)‐2,6,8,9,10a‐pentamethyl‐2,7‐bis{[2‐(trimethylsilyl)ethoxy]methoxy}dodecahydrophenanthrene‐4,10‐dione ( 85 ) were obtained in few synthetic steps.     

An efficient asymmetric synthesis of (4R,8R)‐4,8‐dimethyldecanal,the most active component of natural Tribolure

An asymmetric synthesis of (4R,8R)‐4,8‐dimethyldecanal, the most active component of natural tribolure, was achieved through an asymmetric methylation as a key step and chiral‐pool strategy. Natural tribolure is a mixture of four stereoisomers, (4R,8R)/(4R,8S)/(4S,8R)/(4S,8S), and their ratio is 4/4/1/1. However, the (4R,8R)‐isomer is the most active one. Based on a chiral‐pool strategy, we used a recycled chiral molecular (R)‐4‐(Benzyloxy)‐3‐methylbutanal that we exploited in our previous article. After executing a C5 + C5 + C2 synthetic plan, the target molecule was obtained in nine linear steps and in 36.8% overall yield.     

Alkyne‐Mediated Approach to the Synthesis of (4R,5R)‐5‐Hydroxy‐4‐decanolide and (−)‐Muricatacin

The asymmetric synthesis of two naturally occurring 5‐hydroxy‐γ‐butyrolactones, (4R,5R)‐5‐hydroxy‐4‐decanolide ( 1a ) and (?)‐muricatacin ( 2 ), is described using a general alkyne‐mediated strategy. The key steps involved are Sonogashira coupling for the desired carbon‐chain extension followed by Sharpless asymmetric dihydroxylation to construct the hydroxy‐lactone framework.     

(-)-（3S, 6R）-3, 6-羟基-10-甲基十一酸及其三聚体的全合成

以廉价易得的异戊基溴为起始原料,以烯丙基二异松莰烷基硼烷参与的不对称烯丙基化反应和Yamaguchi酯化反应为关键步骤,实现了对(-)-(3S,6R)-3,6-二羟基-10-甲基十一酸(总收率27.5％)及其三聚体(总收率24.5％)的不对称全合成。     

Enantioselective Access to (−)‐Ambrox® Starting from β‐Farnesene

Starting from inexpensive (E)‐β‐farnesene ( 1 ), an eight‐step enantioselective synthesis of the olfactively precious Ambrox^® ((?)‐ 2a ) has been performed. The crucial step is the catalytic asymmetric isomerization of (2E,6E)‐N,N‐diethylfarnesylamine ( 3 ) to the corresponding enamine (?)‐(R,E)‐ 4a , applying Takasago's well‐known industrial methodology. The resulting dihydrofarnesal ((+)‐(R)‐ 5 ) (90% yield, 96% ee), obtained after in situ hydrolysis (AcOH, H₂O), was then cyclized under catalytic SnCl₄ conditions, via its corresponding unreported enol acetate (?)‐(R)‐ 4b , to afford trans‐decalenic aldehyde (+)‐ 6a . Subsequent transformations furnished bicyclic ketone (?)‐ 8a and unsaturated nitrile (+)‐ 11 , both reported as intermediates to access to (?)‐ 2a .     

Metabolism of Deuterated Isomeric 6,7‐Dihydroxydodecanoic Acids in Saccharomyces cerevisiae – Diastereo‐ and Enantioselective Formation and Characterization of 5‐Hydroxydecano‐4‐lactone (=4,5‐Dihydro‐5‐(1‐hydroxyhexyl)furan‐2(3H)‐one) Isomers

The chemical synthesis of deuterated isomeric 6,7‐dihydroxydodecanoic acid methyl esters 1 and the subsequent metabolism of esters 1 and the corresponding acids 1a in liquid cultures of the yeast Saccharomyces cerevisiae was investigated. Incubation experiments with (6R,7R)‐ or (6S,7S)‐6,7‐dihydroxy(6,7‐²H₂)dodecanoic acid methyl ester ((6R,7R)‐ or (6S,7S)‐(6,7‐²H₂)‐ 1 , resp.) and (±)‐threo‐ or (±)‐erythro‐6,7‐dihydroxy(6,7‐²H₂)dodecanoic acid ((±)‐threo‐ or (±)‐erythro‐(6,7‐²H₂)‐ 1a , resp.) elucidated their metabolic pathway in yeast (Tables 1–3). The main products were isomeric ²H‐labeled 5‐hydroxydecano‐4‐lactones 2 . The absolute configuration of the four isomeric lactones 2 was assigned by chemical synthesis via Sharpless asymmetric dihydroxylation and chiral gas chromatography (Lipodex ^® E). The enantiomers of threo‐ 2 were separated without derivatization on Lipodex ^® E; in contrast, the enantiomers of erythro‐ 2 could be separated only after transformation to their 5‐O‐(trifluoroacetyl) derivatives. Biotransformation of the methyl ester (6R,7R)‐(6,7‐²H₂)‐ 1 led to (4R,5R)‐ and (4S,5R)‐(2,5‐²H₂)‐ 2 (ratio ca. 4 : 1; Table 2). Estimation of the label content and position of (4S,5R)‐(2,5‐²H₂)‐ 2 showed 95% label at C(5), 68% label at C(2), and no ²H at C(4) (Table 2). Therefore, oxidation and subsequent reduction with inversion at C(4) of 4,5‐dihydroxydecanoic acid and transfer of ²H from C(4) to C(2) is postulated. The 5‐hydroxydecano‐4‐lactones 2 are of biochemical importance: during the fermentation of Streptomyces griseus, (4S,5R)‐ 2 , known as L‐factor, occurs temporarily before the antibiotic production, and (?)‐muricatacin (=(4R,5R)‐5‐hydroxy‐heptadecano‐4‐lactone), a homologue of (4R,5R)‐ 2 , is an anticancer agent.     

Asymmetric Total Synthesis of (‐)‐Octahydro‐1H‐benzofuro[3,2‐e]isoquinoline,A Partial Structure of Morphine

Octahydro‐1 H‐benzofuro[3,2‐e]isoquinolines, which possess the ACNO partial structure of morphine, displayed potent oral analgesic and narcotic‐antagonism activity. However, due to inefficiency in their synthesis the ACNO derivatives have not been developed for clinical use. Here, we report in detail the first asymmetric total synthesis of (‐)‐octahydro‐1 H‐benzofuro[3,2‐e]isoquinoline as exemplified by the preparation of (‐)‐ 1 and (‐)‐ 2 . The key intermediate (+)‐5‐hydroxy‐3,4,5,6,7,8‐hexahydro‐1 H‐isoquinoline‐2‐carboxylic acid ethyl ester ((+)‐ 5 ) was prepared in 81% yield and with 100% ee by asymmetric reduction of 5‐oxo‐3,4,5,6,7,8‐hexahydro‐1 H‐isoquinoline‐2‐carboxylic acid ethyl ester ( 6 ) using RuCl[(R,R)‐Tsdpen](p‐cymene) as catalyst with a S/C of 200. The three chiral centers of ACNO skeleton were constructed via a reaction sequence of asymmetric transfer hydrogenation, Heck reaction, and catalytical hydrogenation, and all of these stereoselective reactions were metal‐catalyzed (i.e. Ru, Pd, and Pt, respectively).     

The First Stereoselective Total Synthesis of Naturally Occurring,Bioactive (3R,5R)‐1‐(4‐Hydroxyphenyl)‐7‐phenylheptane‐3,5‐diol and the Synthesis of Its Enantiomer

The first stereoselective total synthesis of the naturally occurring anti‐emetic diarylheptanoid (3R,5R)‐1‐(4‐hydroxyphenyl)‐7‐phenylheptane‐3,5‐diol ( 1 ) was accomplished starting from 4‐hydroxybenzaldehyde and involving a Sharpless kinetic resolution and an asymmetric epoxidation as the key steps (Scheme 2). The enantiomer 1a of this compound was also simultaneously prepared.     

Enantioselective Entry to the Homalium Alkaloid Hoprominol: Synthesis of an (R,R,R)‐Hoprominol Derivative

The diastereoselective synthesis of the N‐ and O‐protected hoprominol derivative (R,R,R)‐ 6 is described. The building up of the bicyclic O‐silylated and di(N‐tosylated) asymmetric scaffold 6 succeeded by convergent preparation of the two basic chiral azalactam units 7a and 7b and their subsequent iterative linking by a known method (Scheme 5). Both 4‐alkyl‐hexahydro‐1,5‐diazocin‐2(1H)‐ones 7a and 7b were prepared from the chiral β‐amino acid portions 10a and 10b , respectively, by application of a set of reactions (e.g., N‐alkylation of 10a , b and Sb(OEt)₃‐assisted cyclization of the resulting open‐chain intermediates) already known. In comparison with the total syntheses of homaline ( 1 ) and homoprine ( 2 ), the newness of the described synthesis lies in the asymmetric approach to the difunctionalized fatty acid derivative 10b starting from (?)‐(S)‐malic acid ( 9 ) (Schemes 3 and 4). Key step in the preparation of 10b was the diastereoselective amination of the optically pure α,β‐unsaturated δ‐hydroxy homoallylic ester 14 via conjugate intramolecular aza‐Michael cyclization of the acylic δ‐(carbamoyloxy) intermediate 11 .     

Solution 1H and 13C NMR of new chiral 1,4‐oxazepinium heterocycles and their intermediates from the reaction of 2,4‐pentanedione with α‐L‐amino acids and (R)‐(—)‐2‐phenylglycinol

The reaction of 2,4‐pentanedione ( 1 ) with (R)‐(—)‐2‐phenylglycine methyl ester ( 2 ), (R)‐(—)‐2‐phenylglycinol ( 3 ) and the proteinogenic amino acids (2S,3R)‐(—)‐2‐amino‐3‐hydroxybutyric acid (L ‐threonine) ( 4 ) and (R)‐(—)‐2‐amino‐3‐mercaptopropionic acid (L ‐cysteine) ( 5 ) methyl esters was investigated. The corresponding enamines 6 , 7 and 8 were isolated and characterized spectroscopically whereas 9 , which is unstable, was transformed in situ into 13 . Treatment of 7 , 8 and 9 with boron trifluoride etherate afforded the new [1,4]oxazepines 10 , 11 and [1,4]thiazepine ( 12 ) as their BF₃O^? salts. The structures of the enamines and their corresponding seven‐membered heterocycles were assessed by 1D and 2D NMR spectroscopy. Variable‐temperature experiments revealed different molecular mobility behavior among these heterocycles. Copyright © 2003 John Wiley & Sons, Ltd.     

Total Synthesis,Stereochemical Assignment,and Field‐Testing of the Sex Pheromone of the Strepsipteran Xenos peckii

The sex pheromone of the endoparasitoid insect Xenos peckii (Strepsiptera: Xenidae) was recently identified as (7E,11E)‐3,5,9,11‐tetramethyl‐7,11‐tridecadienal. Herein we report the asymmetric synthesis of three candidate stereostructures for this pheromone using a synthetic strategy that relies on an sp³–sp² Suzuki–Miyaura coupling to construct the correctly configured C7‐alkene function. Comparison of ¹H NMR spectra derived from the candidate stereostructures to that of the natural sex pheromone indicated a relative configuration of (3R*,5S*,9R*). Chiral gas chromatographic (GC) analyses of these compounds supported an assignment of (3R,5S,9R) for the natural product. Furthermore, in a 16‐replicate field experiment, traps baited with the synthetic (3R,5S,9R)‐enantiomer alone or in combination with the (3S,5R,9S)‐enantiomer captured 23 and 18 X. peckii males, respectively (mean±SE: 1.4±0.33 and 1.1±0.39), whereas traps baited with the synthetic (3S,5R,9S)‐enantiomer or a solvent control yielded no captures of males. These strong field trapping data, in combination with spectroscopic and chiral GC data, unambiguously demonstrate that (3R,5S,9R,7E,11E)‐3,5,9,11‐tetramethyl‐7,11‐tridecadienal is the X. peckii sex pheromone.     

An Expeditious Access to Enantiomerically Pure cis‐Dialkyl‐Substituted γ‐ and δ‐Lactones

A facile general route to enantiomerically pure 3,4‐cis‐dialkyl‐substituted γ‐lactones and 4,5‐cis‐dialkyl‐substituted δ‐lactones by TiCl₄‐mediated Evans asymmetric aldolization as the key step is exemplified by synthesis of cis‐(3R,4R)‐3‐methyldecan‐4‐olide and (4R,5R)‐aerangis lactone.     

The First Synthesis of (4S,5R,6R)‐5,6‐Dihydroxy‐4‐(prop‐1‐en‐2‐yl)cyclohex‐1‐ene‐1‐carboxylic Acid

A putative acid metabolite of a novel highly effective antiparkinsonian agent, (4S,5R,6R)‐5,6‐dihydroxy‐4‐(prop‐1‐en‐2‐yl)cyclohex‐1‐ene‐1‐carboxylic acid ( 5 ), was synthesized for the first time. Several synthetic approaches based on different transformations of O‐bearing monoterpenoids of the pinane and p‐menthane series were developed and tested in the course of the study. Acid 5 was synthesized starting from a commercially available monoterpenoid, (?)‐verbenone, in a total yield of 4.4% over eight steps.     

Three new dihydro‐β‐agarofuran sesquiterpenes from the seeds of Maytenus boaria

As part of a project studying the secondary metabolites extracted from the Chilean flora, we report herein three new β‐agarofuran sesquiterpenes, namely (1S,4S,5S,6R,7R,8R,9R,10S)‐6‐acetoxy‐4,9‐dihydroxy‐2,2,5a,9‐tetramethyloctahydro‐2H‐3,9a‐methanobenzo[b]oxepine‐5,10‐diyl bis(furan‐3‐carboxylate), C₂₇H₃₂O₁₁, ( II ), (1S,4S,5S,6R,7R,9S,10S)‐6‐acetoxy‐9‐hydroxy‐2,2,5a,9‐tetramethyloctahydro‐2H‐3,9a‐methanobenzo[b]oxepine‐5,10‐diyl bis(furan‐3‐carboxylate), C₂₇H₃₂O₁₀, ( III ), and (1S,4S,5S,6R,7R,9S,10S)‐6‐acetoxy‐10‐(benzoyloxy)‐9‐hydroxy‐2,2,5a,9‐tetramethyloctahydro‐2H‐3,9a‐methanobenzo[b]oxepin‐5‐yl furan‐3‐carboxylate, C₂₉H₃₄O₉, ( IV ), obtained from the seeds of Maytenus boaria and closely associated with a recently published relative [Paz et al. (2017). Acta Cryst. C 73 , 451–457]. In the (isomorphic) structures of ( II ) and ( III ), the central decalin system is esterified with an acetate group at site 1 and furoate groups at sites 6 and 9, and differ at site 8, with an OH group in ( II ) and no substituent in ( III ). This position is also unsubstituted in ( IV ), with site 6 being occupied by a benzoate group. The chirality of the skeletons is described as 1S,4S,5S,6R,7R,8R,9R,10S in ( II ) and 1S,4S,5S,6R,7R,9S,10S in ( III ) and ( IV ), matching the chirality suggested by NMR studies. This difference in the chirality sequence among the title structures (in spite of the fact that the three skeletons are absolutely isostructural) is due to the differences in the environment of site 8, i.e. OH in ( II ) and H in ( III ) and ( IV ). This diversity in substitution, in turn, is responsible for the differences in the hydrogen‐bonding schemes, which is discussed.     

Synthesis of 3,4‐Fused γ‐Lactone‐γ‐Lactam Bicyclic Moieties as Multifunctional Synthons for Bioactive Molecules

A short approach for the synthesis of 3,4‐fused γ‐lactone‐γ‐lactam bicyclic systems ( 1 ) in diastereomeric mixtures from chiral D ‐alanine methyl ester hydrochloride is described. The key step towards lactonisation is the reduction of the carbonyl ketone of the 5R‐configured 3,5‐dimethylpyrrolidine‐2,4‐dione diastereomers ( 8 ) via sodium borohydride in the presence of hydrochloric acid. With the presence of ethyl acetyl functionality at C3‐position, ester hydrolysis of 8 occurred concomitantly with keto reduction leading to lactonisation and eventually affording the anticipated (3S,4S,5R), (3R,4R,5R), (3R,4S,5R) and (3S,4R,5R) bicyclic moieties. The formation of the fused systems was confirmed by mass spectroscopy (MS) and nuclear magnetic resonance (NMR) analyses.     

A Direct Synthesis of Nucleoside Analogs Homologated at the 3′‐ and 5′‐Positions

A new route is presented to prepare analogs of nucleosides homologated at the 3′‐ and 5′‐positions. This route, applicable to both the D ‐ and L ‐enantiomeric forms, is suitable for the preparation of monomeric bis‐homonucleosides needed for the synthesis of oligonucleotide analogs. It begins with the known monobenzyl ether 3 of pent‐2‐yne‐1,5‐diol, which is reduced to alkenol 4 . Sharpless asymmetric epoxidation of 4 , followed by opening of the epoxide 5 with allylmagnesium bromide, gives a mixture of diols 6 and 7 . Protection of the primary alcohol as a silyl ether followed by treatment with OsO₄, NaIO₄, and mild acid in MeOH, followed by reduction, yields (2R,3R) {{[(tert‐butyl)diphenylsilyl]oxy}methyl}tetrahydro‐2‐(2‐hydroxyethyl)‐5‐methoxyfuran (=methyl 3‐{{[(tert‐butyl)diphenylsilyl]oxy}methyl}‐2,3,5‐trideoxy‐α/β‐D ‐erythro‐hexafuranoside; 10 ) (Scheme 1). Protected nucleobases are added to this skeleton with the aid of trimethylsilyl triflate (Scheme 2). The o‐toluoyl (2‐MeC₆H₄CO) and p‐anisoyl (4‐MeOC₆H₄CO) groups were used to protect the exocyclic amino group of cytosine. The bis‐homonucleoside analogs 11 and 14a are then converted to monothiol derivatives suitable for coupling (Schemes 3 and 4) to oligonucleotide analogs with bridging S‐atoms. This synthesis replaces a much longer synthesis for analogous nucleoside analogs that begins with diacetoneglucose (=1,2 : 5,6‐di‐O‐isopropylideneglucose), with the stereogenic centers in the final products derived from the Sharpless asymmetric epoxidation. The new route is useful for large‐scale synthesis of these building blocks for the synthesis of oligonucleotide analogs.     

Metabolism of Deuterated threo‐Dihydroxy Fatty Acids in Saccharomyces cerevisiae: Enantioselective Formation and Characterization of Hydroxylactones and γ‐Lactones

Biotransformation of (±)‐threo‐7,8‐dihydroxy(7,8‐²H₂)tetradecanoic acids (threo‐(7,8‐²H₂)‐ 3 ) in Saccharomyces cerevisiae afforded 5,6‐dihydroxy(5,6‐²H₂)dodecanoic acids (threo‐(5,6‐²H₂)‐ 4 ), which were converted to (5S,6S)‐6‐hydroxy(5,6‐²H₂)dodecano‐5‐lactone ((5S,6S)‐(5,6‐²H₂)‐ 7 ) with 80% e.e. and (5S,6S)‐5‐hydroxy(5,6‐²H₂)dodecano‐6‐lactone ((5S,6S)‐5,6‐²H₂)‐ 8 ). Further β‐oxidation of threo‐(5,6‐²H₂)‐ 4 yielded 3,4‐dihydroxy(3,4‐²H₂)decanoic acids (threo‐(3,4‐²H₂)‐ 5 ), which were converted to (3R,4R)‐3‐hydroxy(3,4‐²H₂)decano‐4‐lactone ((3R,4R)‐ 9 ) with 44% e.e. and converted to ²H‐labeled decano‐4‐lactones ((4R)‐(3‐²H₁)‐ and (4R)‐(2,3‐²H₂)‐ 6 ) with 96% e.e. These results were confirmed by experiments in which (±)‐threo‐3,4‐dihydroxy(3,4‐²H₂)decanoic acids (threo‐(3,4‐²H₂)‐ 5 ) were incubated with yeast. From incubations of methyl (5S,6S)‐ and (5R,6R)‐5,6‐dihydroxy(5,6‐²H₂)dodecanoates ((5S,6S)‐ and (5R,6R)‐(5,6‐²H₂)‐ 4a ), the (5S,6S)‐enantiomer was identified as the precursor of (4R)‐(3‐²H₁)‐ and (2,3‐²H₂)‐ 6 ). Therefore, (4R)‐ 6 is synthesized from (3S,4S)‐ 5 by an oxidation/keto acid reduction pathway involving hydrogen transfer from C(4) to C(2). In an analogous experiment, methyl (9S,10S)‐9,10‐dihydroxyoctadecanoate ((9S,10S)‐ 10a ) was metabolized to (3S,4S)‐3,4‐dihydroxydodecanoic acid ((3S,4S)‐ 15 ) and converted to (4R)‐dodecano‐4‐lactone ((4R)‐ 18 ).     

Total Syntheses of the Spermine Alkaloids (−)‐(R,R)‐Hopromine and (±)‐Homaline

The diastereoselective synthesis of the spermine alkaloid (R,R)‐hopromine ( 2 ) is described. The as yet unknown absolute configuration of naturally occurring (−)‐hopromine ( 2 ) is (R,R) and was established by comparison of the reported specific rotation of the natural product with that of the synthetic one. Preparation of the characteristic bis‐8‐membered lactam scaffold was carried out by convergent build‐up of basic chiral azalactam units 21a and 21b and subsequent iterative linking (Schemes 5 and 6). Key steps in the analogous syntheses of 4‐alkyl‐hexahydro‐1,5‐diazocin‐2(1H)‐ones 21a and 21b were the introduction of the unbranched alkyl side chains into their common precursor 14 via cuprate reaction and the Sb(OEt)₃‐assisted cyclization of the open‐chain intermediates 20a and 20b , respectively (Schemes 3 and 4). The chiral iodoester 14 was prepared from commercially available (+)‐L ‐aspartic acid ( 12 ). Based on the synthetic strategy developed for (R,R)‐hopromine ( 2 ), a rapid access to the parent alkaloid homaline ( 1 ) in its (±)‐form is given.